Skip to main content

FDA recall, , Moderate risk

Philips EPIQ and Affiniti Diagnostic Ultrasound Systems

Philips EPIQ and Affiniti ultrasound systems may show incorrect values in their results box or final report because of software issues.

Philips Ultrasound began this recall on Mar 11, 2022. FDA posted it on Nov 12, 2026; it is still open. Still check yours.

What happened

Philips Ultrasound, LLC of Bothell, Washington is recalling 995 Philips EPIQ series and Affiniti series Diagnostic Ultrasound Systems with the Auto Measure licensed Option. The company started the recall on its own, on March 11, 2022. Due to software issues, the systems may display incorrect values in the results box, final report, or both. This may lead to the need for re-measurement of values.

The affected systems run Software Versions 9.0 and 9.0.1. The company notified customers by letter. The systems were distributed in 48 U.S. states and territories, including the District of Columbia and Puerto Rico, and also in Argentina and Australia. The intended use of the EPIQ series systems is diagnostic ultrasound imaging and fluid flow analysis of the human body.

What to do

If yours is listed below, or you can't tell:

  1. Check the lot against the recall notice and ask your provider or supplier before you stop using it.

Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

Incomplete list: 33 of 1,028 other codes shown.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Product details

    Philips EPIQ series and Affiniti series Diagnostic Ultrasound Systems with the Auto Measure licensed Option with Software Versions 9.0 and 9.0.1. Model Numbers: 795117, 795118, 795190, 795200, 795201, 795204, 795205, 795208, 795210, 795218, 795231, 795232 and 795234 The intended use of EPIQ Series Diagnostic Ultrasound Systems is diagnostic ultrasound imaging and fluid flow analysis of the human body.

    UDI-DI
    • 00884838097841
    • 00884838056244
    • 00884838097148
    • 00884838106598
    Other code
    • US121B0844
    • US914D0576
    • US121R0746
    • US121R0747
    • US121R0748
    • US121R0749
    • US121R0750
    • US121R0751
    • US121R0752
    • US121R0753
    • US121R0754
    • US121R0794
    • US121R0795
    • US121R0796
    • US121R0797
    • US121R0798
    • US121R0799
    • US121R0800
    • US121R0801
    • US121R0802
    • US121R0803
    • US121R0804
    • US121R0897
    • US121R1936
    • US121R2004
    • US121R2005
    • US122R0287
    • US122R0338
    • US122R0339
    • US122R0340
    • US221R0237
    • US321R0826
    • US321R1074

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Distributed in Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming, and in Argentina, Australia, Austria, Belgium, Colombia, Croatia, Denmark, Finland, France, Germany, Hong Kong, India, Italy, Martinique, Monaco, Netherlands, New Zealand, Nicaragua, Poland, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates and United Kingdom.

Recalled by
Philips Ultrasound, LLCBothell, Washington
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100162
Recall number
Z-0428-2027
Quantity recalled
995 systems
Recall type
Started by the company
How the company first told customers
Letter

All recalls from Philips Ultrasound, LLC

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. Philips Ultrasound began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 14, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Philips EPIQ and Affiniti Diagnostic Ultrasound Systems Recall.” Recall Canary. https://recallcanary.com/recall/fda/philips-epiq-series-and-affiniti-series-diagnostic-ultrasound-systems.